FFCP PHASE2:Hg19::chr16:65160001..65160033,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr16:65160001..65160033, - |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr16:65160001..65160033, - |
| Coexpression cluster: | C2382_large_Fibroblast_Mesothelial_Mesenchymal_mesothelioma_mesenchymal_carcinoid |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr16:65160001..65160033- |
|---|
0
20
40
60
80
100
120
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| mesothelial cell | 1.88e-13 | 19 |
| fibroblast | 3.00e-13 | 76 |
| skin fibroblast | 9.99e-11 | 23 |
Showing 1 to 3 of 3 entries
| Ontology term | p-value | n |
|---|---|---|
| female gonad | 7.22e-09 | 13 |
| right ovary | 6.06e-07 | 5 |
Showing 1 to 2 of 2 entries
| Ontology term | p-value | n |
|---|---|---|
| ovarian cancer | 1.51e-15 | 14 |
| musculoskeletal system disease | 3.83e-09 | 5 |
| myotonic disease | 3.83e-09 | 5 |
| muscle tissue disease | 3.83e-09 | 5 |
| myopathy | 3.83e-09 | 5 |
| muscular disease | 3.83e-09 | 5 |
| myotonic dystrophy | 3.83e-09 | 5 |
| neuroectodermal tumor | 4.04e-07 | 10 |
| female reproductive organ cancer | 9.10e-07 | 27 |
Showing 1 to 9 of 9 entries
